Simris Alg AB (OSTO:SIMRIS B) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SIMRIS B Simris Alg AB OSTO:SIMRIS B
19 GF Score
Price kr0.11
GF Value kr0.03
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Simris Alg AB Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

OSTO:SIMRIS B
19GF Score
Simris Alg AB OSTO:SIMRIS B
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Simris Alg AB (OSTO:SIMRIS B) Overvalued in 2026?

Based on GuruFocus' analysis, Simris Alg AB stock appears to be overvalued. The current stock price of kr0.11 is trading 273.3% above its estimated GF Value™ of kr0.03. GuruFocus considers Simris Alg AB to be Significantly Overvalued.

Key valuation signals for OSTO:SIMRIS B:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: kr0.03 vs. price of kr0.11 (273.3% above fair value)
  • GF Score™: 19/100 with 6 warning signs

No single metric tells the full story. See the OSTO:SIMRIS B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Simris Alg AB Business Description

Other Exchanges 5LU:Germany
Address Herrestadsvagen 24A, Hammenhog, SWE, 276 50
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
19GF Score

Get the complete analysis for OSTO:SIMRIS B

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.11
Price
kr0.03
GF Value